14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:OPHT
Delisted

Ophthotech Corporation Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$16.10
+0 (+0%)
At Close: Aug 17, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile
Currently predicting for Thu, 25 Apr 2024

OPHT Predictions History

7 years ago
 AJR predicted that OPHT for 2016-12-13 is going $21.32 (303.02%)

Rank:

7 years ago
 Abhi.1744 predicted that OPHT for 2016-12-13 is going $5.68 (7.37%)

Rank:

7 years ago
 Abdu predicted that OPHT for 2016-12-13 is going $5.52 (4.35%)

7 years ago
 JS predicted that OPHT for 2016-12-13 is going $13.04 (146.50%)

Click to get the best stock tips daily for free!

About Ophthotech Corporation

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate, Fovista, an anti-platelet derived growth factor, is in Phase III clinical development for use in combination with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration (AMD). The company is also developing Zimura, an inhibitor of complement fac... OPHT Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT